- Home
- CAN vs ANGO Comparison
CAN vs ANGO Comparison
Compare CAN & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAN | ANGO |
|---|---|---|
| Founded | 2013 | 1988 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 511.2M | 530.2M |
| IPO Year | 2019 | 2004 |
Fundamental Metrics
Financial Performance| Metric | CAN | ANGO |
|---|---|---|
| Price | $0.67 | $12.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $3.56 | ★ $19.33 |
| AVG Volume (30 Days) | ★ 18.5M | 398.6K |
| Earning Date | 11-18-2025 | 01-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $422,228,000.00 | $300,718,000.00 |
| Revenue This Year | $92.55 | $8.18 |
| Revenue Next Year | $41.93 | $5.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 83.87 | 2.73 |
| 52 Week Low | $0.53 | $8.27 |
| 52 Week High | $2.47 | $13.99 |
Technical Indicators
Market Signals| Indicator | CAN | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 32.69 | 47.73 |
| Support Level | $0.71 | $12.76 |
| Resistance Level | $0.89 | $13.91 |
| Average True Range (ATR) | 0.06 | 0.37 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 2.13 | 7.83 |
Price Performance
Historical ComparisonAbout CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.